ENZY Enzymotec Ltd. - Ordinary Shares (delisted)

Enzymotec Ltd., (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid based nutritional ingredients and medical foods, announced today that Dr. Ariel Katz, the Company’s Chief Executive Officer, is scheduled to present at the Jefferies Industrial Conference, being held August 9 – 11, 2016 in New York City and the Canaccord Genuity Annual Growth Conference, being held August 10 – 11, 2016 in Boston.

Details for the Company presentation are as follows:

Conference:		Jefferies Industrial Conference
Date:		Wednesday, August 10, 2016
Time:		10:40AM ET
Conference:		Canaccord Genuity Annual Growth Conference
Date:		Thursday, August 11, 2016
Time:		10:30AM ET

About Enzymotec Ltd.

Enzymotec is a leading global supplier of specialty lipid-based products and solutions. The Company develops, manufactures, and markets innovative bio-active lipid based nutritional ingredients and medical foods, driven by a deep core of cutting-edge, proprietary technologies intended to improve people’s health.  For more information, visit www.enzymotec.com.

Contact:

The Ruth Group
Tram Bui / Lee Roth
(646) 536-7035/7012
tbui@theruthgroup.com
lroth@theruthgroup.com